FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3114446179> ?p ?o ?g. }

• W3114446179 endingPage "12367" @default.
• W3114446179 startingPage "12358" @default.
• W3114446179 abstract "OBJECTIVE The purpose of this study was to conduct a systematic review and meta-analysis analyzing the efficacy of zoledronic acid in improving outcomes with percutaneous vertebroplasty (PVP) and percutaneous kyphoplasty (PKP) surgeries for osteoporotic vertebral compression fracture (OVCF). MATERIALS AND METHODS We electronically searched the databases of PubMed, Embase, ScienceDirect, CENTRAL, and Google Scholar up to 15th September 2020. All types of studies assessing the use of zoledronic acid with PKP/PVP surgeries were included. RESULTS Seven studies were included. On meta-analysis of data from five studies reporting bone mineral density (BMD) as g/cm2, we found a statistically significant increase in BMD in the zoledronic group (MD: 0.14; 95% CI: 0.07, 0.21, I2=97%; p<0.001). On pooled analysis of two studies reporting T scores, a similar result in favour of the zoledronic acid group was noted (MD: 0.60; 95% CI: 0.23, 0.98, I2=76%; p=0.002). We also found a statistically significant reduction in pain scores (MD: -1.23; 95% CI: -1.59, -0.86, I2=97%; p<0.00001), ODI scores (MD: -9.54; 95% CI: -12.76, -6.31, I2=95%; p<0.00001) and serum type I procollagen peptide (CTX) levels (MD: -0.19; 95% CI: -0.25, -0.12, I2=98%; p<0.00001) with zoledronic acid as compared to control. Our analysis also found a significantly reduced risk of further vertebral fractures in patients receiving zoledronic acid as compared to control (RR: 0.17; 95% CI: 0.07, 0.39, I2=0%; p<0.00001). CONCLUSIONS Our review indicates that the use of once-yearly zoledronic acid in the peri-operative period of PVP/PKP procedures for patients with OVCF leads to significant improvement of BMD, reduced pain scores, better ODI scores, and reduced incidence of further vertebral fractures. Our results have clinical significance as it encourages the use of zoledronic acid for such patients for better clinical outcomes." @default.
• W3114446179 created "2021-01-05" @default.
• W3114446179 creator A5017549107 @default.
• W3114446179 creator A5020527857 @default.
• W3114446179 creator A5021384744 @default.
• W3114446179 creator A5024102308 @default.
• W3114446179 date "2020-12-01" @default.
• W3114446179 modified "2023-09-23" @default.
• W3114446179 title "Efficacy of zoledronic acid with percutaneous kyphoplasty/vertebroplasty in the treatment of osteoporotic vertebral compression fractures: a systematic review and meta-analysis." @default.
• W3114446179 doi "https://doi.org/10.26355/eurrev_202012_24030" @default.
• W3114446179 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33336756" @default.
• W3114446179 hasPublicationYear "2020" @default.
• W3114446179 type Work @default.
• W3114446179 sameAs 3114446179 @default.
• W3114446179 citedByCount "1" @default.
• W3114446179 countsByYear W31144461792023 @default.
• W3114446179 crossrefType "journal-article" @default.
• W3114446179 hasAuthorship W3114446179A5017549107 @default.
• W3114446179 hasAuthorship W3114446179A5020527857 @default.
• W3114446179 hasAuthorship W3114446179A5021384744 @default.
• W3114446179 hasAuthorship W3114446179A5024102308 @default.
• W3114446179 hasConcept C126322002 @default.
• W3114446179 hasConcept C141071460 @default.
• W3114446179 hasConcept C2776326535 @default.
• W3114446179 hasConcept C2776541429 @default.
• W3114446179 hasConcept C2776886416 @default.
• W3114446179 hasConcept C2777251235 @default.
• W3114446179 hasConcept C2779386548 @default.
• W3114446179 hasConcept C2779766741 @default.
• W3114446179 hasConcept C71924100 @default.
• W3114446179 hasConcept C95190672 @default.
• W3114446179 hasConceptScore W3114446179C126322002 @default.
• W3114446179 hasConceptScore W3114446179C141071460 @default.
• W3114446179 hasConceptScore W3114446179C2776326535 @default.
• W3114446179 hasConceptScore W3114446179C2776541429 @default.
• W3114446179 hasConceptScore W3114446179C2776886416 @default.
• W3114446179 hasConceptScore W3114446179C2777251235 @default.
• W3114446179 hasConceptScore W3114446179C2779386548 @default.
• W3114446179 hasConceptScore W3114446179C2779766741 @default.
• W3114446179 hasConceptScore W3114446179C71924100 @default.
• W3114446179 hasConceptScore W3114446179C95190672 @default.
• W3114446179 hasIssue "23" @default.
• W3114446179 hasLocation W31144461791 @default.
• W3114446179 hasOpenAccess W3114446179 @default.
• W3114446179 hasPrimaryLocation W31144461791 @default.
• W3114446179 hasRelatedWork W1497018112 @default.
• W3114446179 hasRelatedWork W2390623684 @default.
• W3114446179 hasRelatedWork W2413334457 @default.
• W3114446179 hasRelatedWork W2473917271 @default.
• W3114446179 hasRelatedWork W2746383343 @default.
• W3114446179 hasRelatedWork W2762956910 @default.
• W3114446179 hasRelatedWork W2791964189 @default.
• W3114446179 hasRelatedWork W2910104570 @default.
• W3114446179 hasRelatedWork W2955827316 @default.
• W3114446179 hasRelatedWork W2962025676 @default.
• W3114446179 hasRelatedWork W2965703243 @default.
• W3114446179 hasRelatedWork W3005826352 @default.
• W3114446179 hasRelatedWork W3046007330 @default.
• W3114446179 hasRelatedWork W3148777998 @default.
• W3114446179 hasRelatedWork W3151510764 @default.
• W3114446179 hasRelatedWork W3157811172 @default.
• W3114446179 hasRelatedWork W3157910532 @default.
• W3114446179 hasRelatedWork W3202163037 @default.
• W3114446179 hasRelatedWork W3207641568 @default.
• W3114446179 hasRelatedWork W3209069564 @default.
• W3114446179 hasVolume "24" @default.
• W3114446179 isParatext "false" @default.
• W3114446179 isRetracted "false" @default.
• W3114446179 magId "3114446179" @default.
• W3114446179 workType "article" @default.